2018 Q1 Form 10-Q Financial Statement

#000122460818000019 Filed on May 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $1.008B $1.071B
YoY Change -5.87% 11.48%
Cost Of Revenue $586.6M $669.3M
YoY Change -12.36% 8.13%
Gross Profit $421.2M $401.4M
YoY Change 4.93% 17.57%
Gross Profit Margin 41.79% 37.49%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $78.70M $70.00M
YoY Change 12.43% 2.64%
% of Gross Profit 18.68% 17.44%
Operating Expenses $866.1M $943.2M
YoY Change -8.17% 5.72%
Operating Profit $94.90M -$541.8M
YoY Change -117.52% -1.63%
Interest Expense $33.60M $30.80M
YoY Change 9.09% 11.19%
% of Operating Profit 35.41%
Other Income/Expense, Net
YoY Change
Pretax Income $108.1M $96.70M
YoY Change 11.79% 138.77%
Income Tax $23.80M $34.40M
% Of Pretax Income 22.02% 35.57%
Net Earnings $84.30M $62.30M
YoY Change 35.31% 36.92%
Net Earnings / Revenue 8.36% 5.82%
Basic Earnings Per Share $0.50 $0.36
Diluted Earnings Per Share $0.50 $0.36
COMMON SHARES
Basic Shares Outstanding 167.1M shares 173.4M shares
Diluted Shares Outstanding 169.7M shares 175.1M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $726.4M $884.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $27.42B $26.39B
YoY Change 3.9% 5.82%
Other Assets $450.0M $698.0M
YoY Change -35.53% -15.8%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $32.81B $31.98B
YoY Change 2.61% 1.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $3.972B $4.195B
YoY Change -5.32% 1.92%
Other Long-Term Liabilities $869.0M $798.0M
YoY Change 8.9% 1.14%
Total Long-Term Liabilities $4.841B $4.993B
YoY Change -3.04% 1.79%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $4.841B $4.993B
Total Liabilities $28.19B $27.82B
YoY Change 1.33% 2.16%
SHAREHOLDERS EQUITY
Retained Earnings $576.7M $650.1M
YoY Change -11.29% 71.08%
Common Stock $3.077B $3.215B
YoY Change -4.28% -2.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.848B $4.487B
YoY Change
Total Liabilities & Shareholders Equity $32.81B $31.98B
YoY Change 2.61% 1.65%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $84.30M $62.30M
YoY Change 35.31% 36.92%
Depreciation, Depletion And Amortization $78.70M $70.00M
YoY Change 12.43% 2.64%
Cash From Operating Activities $72.20M $143.4M
YoY Change -49.65% -0.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $7.600M $8.900M
YoY Change -14.61% 134.21%
Cash From Investing Activities -$98.10M $107.0M
YoY Change -191.68% -30.97%
FINANCING ACTIVITIES
Cash Dividend Paid $15.40M $14.00M
YoY Change 10.0% 10.24%
Common Stock Issuance & Retirement, Net $4.600M $36.90M
YoY Change -87.53% -61.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$5.000M -$33.90M
YoY Change -85.25% -64.39%
NET CHANGE
Cash From Operating Activities $72.20M $143.4M
Cash From Investing Activities -$98.10M $107.0M
Cash From Financing Activities -$5.000M -$33.90M
Net Change In Cash -$30.90M $216.5M
YoY Change -114.27% 6.44%
FREE CASH FLOW
Cash From Operating Activities $72.20M $143.4M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 cno Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-295800000 USD
CY2018Q1 cno Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
-87800000 USD
CY2017Q4 cno Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs
AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts
-292600000 USD
CY2018Q1 cno Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs
AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts
-237600000 USD
CY2017Q4 cno Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits
AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits
-94000000 USD
CY2018Q1 cno Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits
AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits
-89700000 USD
CY2017Q4 cno Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities
AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities
-335400000 USD
CY2018Q1 cno Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities
AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities
-245800000 USD
CY2017Q4 cno Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized
2600000 USD
CY2018Q1 cno Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized
3400000 USD
CY2017Q4 cno Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments
2227300000 USD
CY2018Q1 cno Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments
AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments
1551800000 USD
CY2018Q1 cno Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis
AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis
0.03
CY2018Q1 cno Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent
AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent
0.58
CY2018Q1 cno Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent
AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent
0.85
CY2017Q4 cno Available For Sale Securities Debt Maturities Amortized Cost Subtotal
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostSubtotal
15334100000 USD
CY2018Q1 cno Available For Sale Securities Debt Maturities Amortized Cost Subtotal
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostSubtotal
15700600000 USD
CY2017Q4 cno Available For Sale Securities Debt Maturities Fair Value Subtotal
AvailableForSaleSecuritiesDebtMaturitiesFairValueSubtotal
17275500000 USD
CY2018Q1 cno Available For Sale Securities Debt Maturities Fair Value Subtotal
AvailableForSaleSecuritiesDebtMaturitiesFairValueSubtotal
17022400000 USD
CY2018Q1 cno Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss
AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss
900000 USD
CY2018Q1 cno Available For Sale Securities Value Of Securities Sold
AvailableForSaleSecuritiesValueOfSecuritiesSold
444300000 USD
CY2017Q1 cno Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes
BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes
955700000 USD
CY2018Q1 cno Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes
BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes
911000000 USD
CY2017Q4 cno Borrowings Related To Variable Interest Entities
BorrowingsRelatedToVariableInterestEntities
1410700000 USD
CY2018Q1 cno Borrowings Related To Variable Interest Entities
BorrowingsRelatedToVariableInterestEntities
1410500000 USD
CY2017Q4 cno Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities
CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities
578400000 USD
CY2018Q1 cno Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities
CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities
610800000 USD
CY2017Q4 cno Cash And Cash Equivalents Held By Variable Interest Entities
CashAndCashEquivalentsHeldByVariableInterestEntities
178900000 USD
CY2018Q1 cno Cash And Cash Equivalents Held By Variable Interest Entities
CashAndCashEquivalentsHeldByVariableInterestEntities
115600000 USD
CY2017Q1 cno Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments
ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments
-91900000 USD
CY2018Q1 cno Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments
ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments
-43100000 USD
CY2017Q1 cno Change In Cash And Cash Equivalents Held By Variable Interest Entities
ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities
0 USD
CY2017Q4 cno Deferred Income Tax Assets Net Including Netof Current Income Tax Payable
DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable
366900000 USD
CY2018Q1 cno Deferred Income Tax Assets Net Including Netof Current Income Tax Payable
DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable
450400000 USD
CY2017Q4 cno Deferred Tax Assets Before Valuation Allowance
DeferredTaxAssetsBeforeValuationAllowance
465300000 USD
CY2018Q1 cno Deferred Tax Assets Before Valuation Allowance
DeferredTaxAssetsBeforeValuationAllowance
532100000 USD
CY2018Q1 cno Distribution Expense Included In Other Costs And Expenses
DistributionExpenseIncludedInOtherCostsAndExpenses
11500000 USD
CY2017Q1 cno Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities
EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities
-1100000 USD
CY2018Q1 cno Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities
EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities
5800000 USD
CY2018Q1 cno Estimated Normalized Annual Taxable Income For Current Year
EstimatedNormalizedAnnualTaxableIncomeForCurrentYear
345000000 USD
CY2018Q1 cno Estimated Normalized Annual Taxable Income For Current Year Life Income
EstimatedNormalizedAnnualTaxableIncomeForCurrentYearLifeIncome
260000000 USD
CY2018Q1 cno Estimated Normalized Annual Taxable Income For Current Year Nonlife Taxable Income
EstimatedNormalizedAnnualTaxableIncomeForCurrentYearNonlifeTaxableIncome
85000000 USD
CY2017Q1 cno Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests
ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests
13900000 USD
CY2018Q1 cno Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests
ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests
13800000 USD
CY2018Q1 cno Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage
FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage
0.30
CY2018Q1 cno Federal Long Term Tax Exempt Rate
FederalLongTermTaxExemptRate
0.0218
CY2018Q1 cno Feerevenuerelatedtodistributionandmarketingagreements
Feerevenuerelatedtodistributionandmarketingagreements
15800000 USD
CY2018Q1 cno Future Cash Tax Payments As A Percent Of Life Insurance Taxable Income Due
FutureCashTaxPaymentsAsAPercentOfLifeInsuranceTaxableIncomeDue
0.65
CY2017Q1 cno Gain Losson Investments Excluding Cash Expenses
GainLossonInvestmentsExcludingCashExpenses
7900000 USD
CY2018Q1 cno Gain Losson Investments Excluding Cash Expenses
GainLossonInvestmentsExcludingCashExpenses
-15200000 USD
CY2018Q1 cno Income Loss From Continuing Operations Before Investment Losses And Income Taxes
IncomeLossFromContinuingOperationsBeforeInvestmentLossesAndIncomeTaxes
4300000 USD
CY2018Q1 cno Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
67900000 USD
CY2017Q1 cno Insurance Policy Benefits
InsurancePolicyBenefits
511800000 USD
CY2018Q1 cno Insurance Policy Benefits
InsurancePolicyBenefits
531400000 USD
CY2017Q4 cno Investment Borrowings
InvestmentBorrowings
1646700000 USD
CY2018Q1 cno Investment Borrowings
InvestmentBorrowings
1646500000 USD
CY2017Q4 cno Investments Held By Variable Interest Entities
InvestmentsHeldByVariableInterestEntities
1526900000 USD
CY2018Q1 cno Investments Held By Variable Interest Entities
InvestmentsHeldByVariableInterestEntities
1583900000 USD
CY2018Q1 cno Investments Held In Limited Partnerships
InvestmentsHeldInLimitedPartnerships
500000000 USD
CY2018Q1 cno Loss Limitation Based On Income Of Life Insurance Company
LossLimitationBasedOnIncomeOfLifeInsuranceCompany
0.35
CY2018Q1 cno Loss Limitation Based On Loss Of Non Life Entities
LossLimitationBasedOnLossOfNonLifeEntities
0.35
CY2017Q1 cno Maturities And Redemptions Of Investments
MaturitiesAndRedemptionsOfInvestments
849300000 USD
CY2018Q1 cno Maturities And Redemptions Of Investments
MaturitiesAndRedemptionsOfInvestments
547100000 USD
CY2017Q1 cno Net Investment Income On General Account Invested Assets
NetInvestmentIncomeOnGeneralAccountInvestedAssets
312000000 USD
CY2018Q1 cno Net Investment Income On General Account Invested Assets
NetInvestmentIncomeOnGeneralAccountInvestedAssets
329100000 USD
CY2017Q1 cno Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios
NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios
75200000 USD
CY2018Q1 cno Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios
NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios
12800000 USD
CY2017Q1 cno Net Sales Purchases Of Trading Securities
NetSalesPurchasesOfTradingSecurities
-35600000 USD
CY2018Q1 cno Net Sales Purchases Of Trading Securities
NetSalesPurchasesOfTradingSecurities
2000000 USD
CY2017Q1 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale
-1100000 USD
CY2018Q1 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale
-600000 USD
CY2017Q1 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax
600000 USD
CY2018Q1 cno Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax
NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax
200000 USD
CY2018Q1 cno Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank
NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank
3 subsidiary
CY2018Q1 cno Number Of Investments Held By Variable Interest Entities In Default
NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault
0 investment
CY2018Q1 cno Number Of Product Distribution Channels
NumberOfProductDistributionChannels
3 distribution_channel
CY2018Q1 cno Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws
NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws
38 state
CY2017Q3 cno Numberof Individuals Appointedto Assume Immediate Controland Power Over Affairs
NumberofIndividualsAppointedtoAssumeImmediateControlandPowerOverAffairs
2 individual
CY2017Q1 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax
-7800000 USD
CY2018Q1 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax
-55700000 USD
CY2017Q1 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax
-52000000 USD
CY2018Q1 cno Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax
OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax
211600000 USD
CY2017Q1 cno Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax
166500000 USD
CY2018Q1 cno Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Arising During Period Net Of Reclassification And Amortization Adjustments Before Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfReclassificationAndAmortizationAdjustmentsBeforeTax
-386800000 USD
CY2017Q1 cno Other Than Temporary Impairment Losses Losseson Other Investments Following Unforeseen Events
OtherThanTemporaryImpairmentLossesLossesonOtherInvestmentsFollowingUnforeseenEvents
5200000 USD
CY2018Q1 cno Ownership Change Threshold Restricting Net Operating Loss Usage
OwnershipChangeThresholdRestrictingNetOperatingLossUsage
0.5
CY2017Q1 cno Policy Acquisition Costs
PolicyAcquisitionCosts
63200000 USD
CY2018Q1 cno Policy Acquisition Costs
PolicyAcquisitionCosts
60200000 USD
CY2017Q4 cno Prepaid Accrued Income Taxes Current
PrepaidAccruedIncomeTaxesCurrent
-9300000 USD
CY2018Q1 cno Prepaid Accrued Income Taxes Current
PrepaidAccruedIncomeTaxesCurrent
7400000 USD
CY2017Q1 cno Pretaxoperatingearnings
Pretaxoperatingearnings
92900000 USD
CY2018Q1 cno Pretaxoperatingearnings
Pretaxoperatingearnings
94900000 USD
CY2017Q1 cno Proceeds From Investment Borrowings Related To Variable Interest Entities
ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities
8700000 USD
CY2018Q1 cno Proceeds From Investment Borrowings Related To Variable Interest Entities
ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities
0 USD
CY2017Q1 cno Purchases Of Investments
PurchasesOfInvestments
1166400000 USD
CY2018Q1 cno Purchases Of Investments
PurchasesOfInvestments
1798700000 USD
CY2018Q1 cno Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
134500000 USD
CY2018Q1 cno Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized
ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized
80600000 USD
CY2017Q1 cno Repayments Of Investment Borrowings Related To Variable Interest Entities
RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities
38100000 USD
CY2018Q1 cno Repayments Of Investment Borrowings Related To Variable Interest Entities
RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities
700000 USD
CY2017Q1 cno Revenues Excluding Realized Gains Losses
RevenuesExcludingRealizedGainsLosses
1048600000 USD
CY2018Q1 cno Revenues Excluding Realized Gains Losses
RevenuesExcludingRealizedGainsLosses
1005900000 USD
CY2017Q1 cno Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests
RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests
14200000 USD
CY2018Q1 cno Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests
RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests
17100000 USD
CY2017Q1 cno Sales Of Investments
SalesOfInvestments
397400000 USD
CY2018Q1 cno Sales Of Investments
SalesOfInvestments
1163100000 USD
CY2017Q1 cno Share Based Compensation Noncash Portion
ShareBasedCompensationNoncashPortion
6300000 USD
CY2018Q1 cno Share Based Compensation Noncash Portion
ShareBasedCompensationNoncashPortion
6800000 USD
CY2017Q1 cno Stock Based Compensation
StockBasedCompensation
7100000 USD
CY2018Q1 cno Stock Based Compensation
StockBasedCompensation
2200000 USD
CY2017Q4 cno Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit
TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit
172500000 USD
CY2017 cno Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit
TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit
172500000 USD
CY2018Q1 cno Unfunded Commitmentsto Limited Partnerships
UnfundedCommitmentstoLimitedPartnerships
275500000 USD
CY2018Q1 cno Valuation Allowance Deferred Tax Asset Valuation Model Forecast Periodof Model
ValuationAllowanceDeferredTaxAssetValuationModelForecastPeriodofModel
P5Y
CY2017Q1 cno Variable Interest Entities Investments Sold
VariableInterestEntitiesInvestmentsSold
20400000 USD
CY2018Q1 cno Variable Interest Entities Investments Sold
VariableInterestEntitiesInvestmentsSold
10800000 USD
CY2017Q1 cno Variable Interest Entities Net Realized Gain Loss On Investments
VariableInterestEntitiesNetRealizedGainLossOnInvestments
2100000 USD
CY2018Q1 cno Variable Interest Entities Net Realized Gain Loss On Investments
VariableInterestEntitiesNetRealizedGainLossOnInvestments
0 USD
CY2018Q1 cno Variable Interest Entity Amortized Cost Securities Held
VariableInterestEntityAmortizedCostSecuritiesHeld
1581900000 USD
CY2018Q1 cno Variable Interest Entity Fixed Maturity Securities Fair Value
VariableInterestEntityFixedMaturitySecuritiesFairValue
1583900000 USD
CY2018Q1 cno Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities
VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities
8800000 USD
CY2018Q1 cno Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities
VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities
6800000 USD
CY2017Q1 cno Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax
VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax
100000 USD
CY2018Q1 cno Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax
VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax
100000 USD
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001224608
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
167356255 shares
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
CNO Financial Group, Inc.
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
335100000 USD
CY2017Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
245900000 USD
CY2018Q1 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
268100000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1212100000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
894300000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1195800000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3073300000 USD
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3075600000 USD
CY2017Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
63500000 USD
CY2018Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
71900000 USD
CY2017Q4 us-gaap Assets
Assets
33110300000 USD
CY2018Q1 us-gaap Assets
Assets
32809100000 USD
CY2017Q1 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
8000000 USD
CY2018Q1 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
7200000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
20702100000 USD
CY2018Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
20820900000 USD
CY2017Q4 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
420000000 USD
CY2018Q1 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
504400000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
31400000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
44700000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
42500000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
130200000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
2159000000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
4320600000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
11100000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
85500000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1426400000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
3715200000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
732600000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
605400000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1508700000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1818000000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1601300000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1881800000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1947300000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1765200000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2052300000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1837400000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
11550000000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
11693200000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
13286800000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
12871900000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
328100000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
424200000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
431300000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
5368000000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
5120300000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
5635400000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
5353100000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22910900000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22375500000 USD
CY2017Q4 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
440600000 USD
CY2018Q1 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
498700000 USD
CY2017Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
974000000 USD
CY2018Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
899700000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
668200000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
884700000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
757300000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
726400000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
216500000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-30900000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
668200000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
884700000 USD
CY2017Q1 us-gaap Ceded Premiums Written
CededPremiumsWritten
26300000 USD
CY2018Q1 us-gaap Ceded Premiums Written
CededPremiumsWritten
24500000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.09
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
166857931 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
167354255 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
166857931 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
167354255 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1700000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
1600000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
169500000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-217200000 USD
CY2016Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
300000 USD
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
0 USD
CY2017Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20600000 USD
CY2018Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5300000 USD
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
914600000 USD
CY2018Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
915100000 USD
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
10400000 USD
CY2018Q1 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
9900000 USD
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017Q1 us-gaap Fees And Commissions
FeesAndCommissions
11800000 USD
CY2018Q1 us-gaap Fees And Commissions
FeesAndCommissions
21200000 USD
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.011
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.002
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.017
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2017Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-5500000 USD
CY2018Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
30900000 USD
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13800000 USD
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18500000 USD
CY2017Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1026800000 USD
CY2018Q1 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1083600000 USD
CY2017Q1 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
500000 USD
CY2018Q1 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
500000 USD
CY2017Q1 us-gaap Deferred Sales Inducements Amortization Expense
DeferredSalesInducementsAmortizationExpense
2100000 USD
CY2018Q1 us-gaap Deferred Sales Inducements Amortization Expense
DeferredSalesInducementsAmortizationExpense
2700000 USD
CY2017Q4 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
42500000 USD
CY2018Q1 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
40300000 USD
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
967900000 USD
CY2018Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
940800000 USD
CY2017Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
4300000 USD
CY2018Q1 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
100000 USD
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
376200000 USD
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
443000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
489600000 USD
CY2018Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
484200000 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
9300000 USD
CY2018Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
9800000 USD
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
48900000 USD
CY2018Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
44300000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities
415800000 USD
CY2018Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities
402400000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
89100000 USD
CY2018Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
89100000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
502600000 USD
CY2018Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
408700000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
165400000 USD
CY2018Q1 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
160600000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
337200000 USD
CY2018Q1 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
248100000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70000000 USD
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
78700000 USD
CY2017Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
47500000 USD
CY2018Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
28700000 USD
CY2017Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14000000 USD
CY2018Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15300000 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.356
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.220
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33900000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5000000 USD
CY2017Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
7900000 USD
CY2018Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-15200000 USD
CY2017Q1 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
16300000 USD
CY2018Q1 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-15200000 USD
CY2017Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
397400000 USD
CY2017Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
8400000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
96700000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
108100000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34400000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23800000 USD
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1500000 USD
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
22100000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
32900000 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1700000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
63200000 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
60200000 USD
CY2017Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
131600000 USD
CY2018Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
25500000 USD
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1634000 shares
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2617000 shares
CY2017Q1 us-gaap Interest Expense
InterestExpense
30800000 USD
CY2018Q1 us-gaap Interest Expense
InterestExpense
33600000 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
20500000 USD
CY2018Q1 us-gaap Interest Paid
InterestPaid
19300000 USD
CY2017Q4 us-gaap Investments
Investments
27854100000 USD
CY2018Q1 us-gaap Investments
Investments
27416000000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
28262800000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
28191900000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33110300000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32809100000 USD
CY2017Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
530300000 USD
CY2018Q1 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
509100000 USD
CY2017Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11521300000 USD
CY2018Q1 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11312200000 USD
CY2018Q1 us-gaap Long Term Debt
LongTermDebt
925000000 USD
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
500000000 USD
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
325000000 USD
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
100000000 USD
CY2017Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
1650600000 USD
CY2018Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
1601200000 USD
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4600000 USD
CY2017Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
14000000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
107000000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98100000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143400000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
72200000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
62300000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
84300000 USD
CY2017Q1 us-gaap Net Investment Income
NetInvestmentIncome
295300000 USD
CY2017Q4 us-gaap Notes Payable
NotesPayable
914600000 USD
CY2018Q1 us-gaap Notes Payable
NotesPayable
915100000 USD
CY2018Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2305700000 USD
CY2017Q4 us-gaap Other Assets
OtherAssets
319500000 USD
CY2018Q1 us-gaap Other Assets
OtherAssets
356000000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
166500000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-386800000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
107200000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-301500000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
0 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
0 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
5100000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
400000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
59300000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-85300000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
215800000 USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-653700000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
106100000 USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-302100000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
58700000 USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-85500000 USD
CY2017Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
210400000 USD
CY2018Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
207600000 USD
CY2017Q4 us-gaap Other Investments
OtherInvestments
924500000 USD
CY2018Q1 us-gaap Other Investments
OtherInvestments
951100000 USD
CY2017Q4 us-gaap Other Liabilities
OtherLiabilities
751800000 USD
CY2018Q1 us-gaap Other Liabilities
OtherLiabilities
869000000 USD
CY2017Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
9600000 USD
CY2018Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-29900000 USD
CY2017Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
8400000 USD
CY2018Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0 USD
CY2017Q1 us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
206800000 USD
CY2018Q1 us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
246200000 USD
CY2017Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
8900000 USD
CY2018Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7600000 USD
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
39800000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
4606800000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
4847500000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
4617200000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
4847500000 USD
CY2018Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
15400000 USD
CY2017Q4 us-gaap Policy Loans Receivable
PolicyLoansReceivable
116000000 USD
CY2018Q1 us-gaap Policy Loans Receivable
PolicyLoansReceivable
116000000 USD
CY2017Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
669300000 USD
CY2018Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
586600000 USD
CY2017Q4 us-gaap Policyholder Funds
PolicyholderFunds
11220700000 USD
CY2018Q1 us-gaap Policyholder Funds
PolicyholderFunds
11254500000 USD
CY2017Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
663800000 USD
CY2018Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
659900000 USD
CY2017Q1 us-gaap Proceeds From Annuities And Investment Certificates
ProceedsFromAnnuitiesAndInvestmentCertificates
359500000 USD
CY2018Q1 us-gaap Proceeds From Annuities And Investment Certificates
ProceedsFromAnnuitiesAndInvestmentCertificates
355600000 USD
CY2017Q1 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
11800000 USD
CY2018Q1 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
21200000 USD
CY2017Q1 us-gaap Proceeds From Insurance Premiums Collected
ProceedsFromInsurancePremiumsCollected
640100000 USD
CY2018Q1 us-gaap Proceeds From Insurance Premiums Collected
ProceedsFromInsurancePremiumsCollected
631400000 USD
CY2017Q1 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
295300000 USD
CY2018Q1 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
298800000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2900000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7900000 USD
CY2018Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-15200000 USD
CY2017Q1 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Assumed
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
12000000 USD
CY2018Q1 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Assumed
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
9300000 USD
CY2017Q1 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
24100000 USD
CY2018Q1 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
23400000 USD
CY2017Q4 us-gaap Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
2175200000 USD
CY2018Q1 us-gaap Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
2153500000 USD
CY2017Q1 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
312900000 USD
CY2018Q1 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
339700000 USD
CY2017Q1 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
200000 USD
CY2018Q1 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
200000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
560400000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
645700000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
576700000 USD
CY2017Q1 us-gaap Revenues
Revenues
1070700000 USD
CY2018Q1 us-gaap Revenues
Revenues
1007800000 USD
CY2017Q4 us-gaap Separate Account Assets
SeparateAccountAssets
5000000 USD
CY2018Q1 us-gaap Separate Account Assets
SeparateAccountAssets
4700000 USD
CY2017Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
5000000 USD
CY2018Q1 us-gaap Separate Accounts Liability
SeparateAccountsLiability
4700000 USD
CY2018Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
200000 shares
CY2017Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
43000000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
4486900000 USD
CY2017Q4 us-gaap Trading Securities
TradingSecurities
284600000 USD
CY2018Q1 us-gaap Trading Securities
TradingSecurities
289600000 USD
CY2017Q4 us-gaap Unearned Premiums
UnearnedPremiums
261700000 USD
CY2018Q1 us-gaap Unearned Premiums
UnearnedPremiums
270300000 USD
CY2017Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
359600000 USD
CY2018Q1 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
350400000 USD
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175065000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175065000 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
169677000 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
169677000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173431000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173431000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167060000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
167060000 shares
CY2018Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.&#160;&#160;We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.&#160;&#160;The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.&#160;&#160;In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.&#160;&#160;In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.&#160;&#160;Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.&#160;&#160;The Company reviews these matters on an ongoing basis.&#160;&#160;When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against Beechwood Re Ltd. ("BRe") based upon BRe&#8217;s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, Case No. 16-cv-7646, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. On March 13, 2018, the District Court granted the motion that had been filed by Feuer, Taylor and Levy to compel arbitration of Washington National's and BCLIC's claims and the litigation is now stayed pending the outcome of the arbitration. Washington National and BCLIC intend to vigorously pursue their claims for damages and other remedies in the arbitration and the litigation described above.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe.&#160; According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business.&#160; The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority by a date to be specified. &#160;We are in the process of assessing the potential impact of this action on the proceedings described in the foregoing paragraph.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions.&#160;&#160;Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.&#160;&#160;We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.&#160;&#160;The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.&#160;&#160;In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries. &#160;Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">38</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia are currently participating in this examination.</font></div></div>

Files In Submission

Name View Source Status
0001224608-18-000019-index-headers.html Edgar Link pending
0001224608-18-000019-index.html Edgar Link pending
0001224608-18-000019.txt Edgar Link pending
0001224608-18-000019-xbrl.zip Edgar Link pending
cno-20180331.xml Edgar Link completed
cno-20180331.xsd Edgar Link pending
cno-20180331_cal.xml Edgar Link unprocessable
cno-20180331_def.xml Edgar Link unprocessable
cno-20180331_lab.xml Edgar Link unprocessable
cno-20180331_pre.xml Edgar Link unprocessable
cno0331201810-q.htm Edgar Link pending
cno03312018ex121.htm Edgar Link pending
cno03312018ex311.htm Edgar Link pending
cno03312018ex312.htm Edgar Link pending
cno03312018ex321.htm Edgar Link pending
cno03312018ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orgchart2017.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending